A significantly higher incidence of CRC was found during initial colonoscopy in the MLH1 group (17%) compared to the MSH2 (8%), MSH6 (5%) and PMS2 groups (7%; p = 0.004). This evidence concerns the gene PMS2 and colorectal carcinoma.